Results 331 to 340 of about 264,442 (390)

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Anti-Oxidative Effect of Dapagliflozin, a Selective Sodium Glucose Transporter-2 Inhibitor, for Cardio-Renal Protection in Patients With Heart Failure With Reduced Ejection Fraction. [PDF]

Cardiol Res
Tsudome R, Suematsu Y, Tashiro K, Ideishi A, Miyazaki M, Yano Y, Arimura T, Hirata T, Fujimi K, Miura SI.   +9 more
europepmc   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Utility of short-term heart rate variability metrics in heart failure with reduced ejection fraction. [PDF]

Heart Rhythm O2
Nagai M, Po SS, Scherlag BJ, Dasari TW.
europepmc   +1 more source

Underutilization of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: A Retrospective Study in Rural Appalachia. [PDF]

Cureus
Sanku K, Nemalikanti S, Adegbile O, Mekala S, Vatsavayi P, Willey A, Husari G, Mamudu HM, Vedantam V.   +8 more
europepmc   +1 more source

Effects of colchicine on depression scale scores of patients with chronic heart failure with reduced ejection fraction: A randomized clinical trial. [PDF]

J Cardiovasc Thorac Res
Taban-Sadeghi M, Khiali S, Karimi M, Shahidi M, Khani E, Mousavi Z, Entezari-Maleki T.   +6 more
europepmc   +1 more source

Correlations between soluble ST2 concentration and the nutritional status in patients with heart failure with reduced ejection fraction — cross-sectional study

Marta Kałużna‐Oleksy, Filip Waśniewski, Magdalena Szczechla, Filip Sawczak, Agata Kukfisz, Helena Krysztofiak, Katarzyna Przytarska, Ewa Straburzyńska‐Migaj, Magdalena Dudek   +8 more
openalex   +2 more sources

Conduction System Pacing Improved Cardiac Functions, Myocardial Work and Functional Capacity in Heart Failure with Reduced Ejection Fraction and Right Bundle Branch Block. [PDF]

J Clin Med
Tóth AZ, Nagy L, Jenei C, Ráduly AP, Sándorfi G, Szabó KM, Kiss A, Nagy LT, Szilágyi GI, Csanádi Z.   +9 more
europepmc   +1 more source